Concepedia

Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist

Tsuyoshi Nakamura, Masayoshi Asano, Yukiko Sekiguchi, Yumiko Mizuno, Kazuhiko Tamaki, Takako Kimura, Futoshi Nara, Yumi Kawase, Takaichi Shimozato, Hiromi Doi,

Bioorganic & Medicinal Chemistry Letters · 2012 · 24 citations · 22 references

DOIFull text

Open access

Concepts

References

22

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Ludwig Kappos, Ernst‐Wilhelm Radue, Paul O’Connor et al. · New England Journal of Medicine · 2010 · 2.6K citations · Full text

, , +14

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

Mehrdad Matloubian, Charles G. Lo, Guy Cinamon et al. · Nature · 2004 · 2.5K citations

, , +9

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

Jeffrey A. Cohen, Frederik Barkhof, Hans‐Peter Hartung et al. · New England Journal of Medicine · 2010 · 2.2K citations · Full text

, , +15

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

Suzanne Mandala, Richard Hajdu, James D. Bergstrom et al. · Science · 2002 · 1.7K citations

, , +17

The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

Volker Brinkmann, Michael D. Davis, Christopher E. Heise et al. · Journal of Biological Chemistry · 2002 · 1.5K citations · Full text

, , +17